<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04191876</url>
  </required_header>
  <id_info>
    <org_study_id>19-0739-ZHH</org_study_id>
    <nct_id>NCT04191876</nct_id>
  </id_info>
  <brief_title>Financial Incentives to Improve Medication Adherence</brief_title>
  <official_title>Financial Incentives to Improve Medication Adherence: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Medication adherence is a challenge in all of medicine and is associated with multiple&#xD;
      negative outcomes. Strategies to better measure and enhance adherence to medication are&#xD;
      urgent and necessary to minimize unwanted health outcomes, hospitalizations, poorer quality&#xD;
      of life and excessive costs for individuals, insurers and caregivers. Recently, behavioral&#xD;
      economics-based approaches have emerged as a promising tool to address this unmet need, but&#xD;
      its effectiveness in oral antipsychotic treatment remains to be assessed. For this project,&#xD;
      investigators will use an app that offers financial incentives to increase compliance for&#xD;
      patients with chronic diseases. Investigators intend to enroll 25 patients in a pilot project&#xD;
      to assess feasibility of offering financial incentives to improve medication adherence in&#xD;
      severe mental illness.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2022</completion_date>
  <primary_completion_date type="Actual">May 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in medication adherence rate</measure>
    <time_frame>Between baseline and study completion (10 weeks)</time_frame>
    <description>Adherence rate will be measured as pills missed/pills prescribed</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Schizo Affective Disorder</condition>
  <condition>Bipolar Disorder</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>Active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This study has only one arm. All patients enrolled will take part in the experimental arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wellth - Financial Incentives</intervention_name>
    <description>Patients who are willing to participate will be offered financial incentives for medication adherence through an app (Wellth) over 10 weeks.</description>
    <arm_group_label>Active</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Psychiatric patients with suspected or confirmed poor oral medication adherence.&#xD;
&#xD;
          2. Age 18-80 years old&#xD;
&#xD;
          3. English speaking, since the app being used is only available in English&#xD;
&#xD;
          4. Owning a Smartphone, since the app requires a Smartphone to work&#xD;
&#xD;
          5. Willing and able to participate.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Acute anger to self or others as per investigator assessment&#xD;
&#xD;
          2. Unwilling or unable to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Zucker Hillside Hospital</name>
      <address>
        <city>Glen Oaks</city>
        <state>New York</state>
        <zip>11004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 2, 2019</study_first_submitted>
  <study_first_submitted_qc>December 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>financial incentives</keyword>
  <keyword>medication adherence</keyword>
  <keyword>severe mental illness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
    <mesh_term>Mood Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

